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With increasing immigration from endemic regions, the incidence of neurocysticercosis in North America is rising. This 
retrospective study was undertaken to examine the role of surgery in those cases presenting with large cystic parenchymal 
and cisternal lesions in the current era of anthclminthic agents administered orally. A total of 237 patients presented 
with newly diagnosed neurocysticercosis to our institution over a recent 5-year period (mean age. 31.2 years). Among 
those who presented with cystic mass lesions predominantly affecting the brain parenchyma and cisternal spaces. 20 
(8.4%; mean age, 40.2 years) with large cystic lesions subsequently underwent surgical intervention, cither because of 
an emergent presentation or because they were refractory to medical management. Clinical presentation included 
increased intracranial pressure, focal neurological deficit, and seizure. Radiographic imaging (computed tomography 
and/or magnetic resonance imaging) demonstrated 12 cases with cisternal lesions, 7 with parenchymal lesions, and 1 
involving both compartments. Based on imaging guidelines, 30 operative procedures (excluding shunt revisions) were 
performed (14 craniotomies, 8 cerebrospinal fluid diversions, 7 stereotactic procedures, and 1 burr hole drainage). 
Fifteen (75%) showed neurological or symptomatic improvement over a median follow-up period of 36.4 months. 
There were three surgery-related complications and no deaths. (Neurosurgery 28:231-237, 1991)
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IN T RO D U C T IO N
Infestation of the central nervous system with the larval 
form ofthe porcine intestinal tapeworm Taenia solium, cys­
ticercosis cerebri, is becoming increasingly common in North 
America because of immigration from endemic regions. 
Symptomatic involvement occurs when man serves as the 
inadvertent intermediate host for the larvae; usually, man is 
the sole asymptomatic definitive host. Infestation occurs from 
the ingestion of contaminated foods (especially uncooked 
vegetables that have been fertilized with porcine manure 
containing proglottids or ova), or autoinfection resulting from 
either reverse peristalsis or anal-oral contamination from 
ingestion of ova released by adult intestinal forms (15. 18, 
41). The disease was first described in the United States by 
Walter Dandy in 1927 (5) and is predominantly an affliction 
of underdeveloped countries, with the majority of cases de­
scribed in developed nations being harbored by immigrants 
(15, 33). O f epidemiological interest to support this was the 
2% incidence reported in an autopsy series in Berlin over a 
century ago (13). In endemic areas, such as central and South 
America, eastern Europe, and Asia, the disease is prevalent; 
in Mexico, general autopsy incidence has been reported as 
3.5 to 4% (3, 36). and it accounts for up to 11% of all 
neurosurgical procedures in selected centers (23). The major­
ity of these cases, however, are asymptomatic (12).
Neurological manifestations occur in 60 to 92% of infesta­
tions (21). Anatomically, the larvae may infest the parenchy­
mal. cisternal (subarachnoid), or ventricular spaces, although 
often, a single case may have involvement of more than one 
compartment. The neurological manifestations of the disease 
are protean, and symptoms depend on the magnitude of the 
infestation, the neuroanatomical location ofthe cysts, and the 
immune response of the host. Other system involvement may 
occur with larval deposition in myocardial or skeletal muscle 
or ocular or cutaneous tissues.
The potential for poor outcomes in both intraventricular
(2, 10) and basilar racemose forms (16, 20, 28, 29, 40) of the 
disease are well recognized. Parenchymal lesions, on the other 
hand, arc acknowledged to occupy the benign end of the 
symptomatic spectrum (14), The introduction of the anthel- 
minthic agents praziquantel (4, 6-8, 18, 31. 34, 35. 38, 43) 
and, more recently, albendazole (8, 9, 35, 37) has had a major 
impact on the management of parenchymal lesions; however, 
the present role of surgery in these cases is not defined. The 
optimal surgical management of large basilar cisternal cysts, 
which are more frequently refractory to medical treatment, is 
also not established in the contemporary literature. Wc have 
therefore reviewed our surgical experience with such lesions 
in an attempt to determine the current role of surgery in their 
management.
CLIN ICAL M ATERIAL AN D  METHODS
Diagnostic criteria
The diagnosis of ncuroeysticcrcosis is confirmed by a number of 
epidemiological, symptomatic, serological, and radiographic findings 
consistent with the infestation. In the authors’ experience, the radio­
graphic evaluation, especially computed tomographic (CT) scans and. 
more recently, magnetic resonance imaging (M R I), in conjunction 
with cerebrospinal fluid (CSF) serology, offer the most specific diag­
nostic information. The soft tissue or muscular calcifications evident 
on long bone radiographs are reliable and specific but are not always 
present (10. 15, 39). Examination of stool for ova is routinely per­
formed but is not sensitive, nor is it pathognomonic for determination 
o f intracranial pathology: however, this information is o f value from 
an epidemiological perspective by virtue of identifying a potential 
infectious source. CSF or serum eosinophilia is indicative o f a para­
sitic infection and may offer supportive evidence but is neither specific 
nor sensitive. Serological assays are well known to be of limited 
diagnostic value, being positive in only up to 60% of previously 
reported series of cysticercosis cerebri (27), ln addition, the delay in 
obtaining results offers limited clinical guidance in the treatment of
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the symptomatic patient. Newer serological methodologies hold fu­
ture hope for increased diagnostic accuracy, as a recently published 
series from Mexico reports an 87% sensitivity with CSF serology 
using enzyme-linked immunoadsorbent assay (32).
Case selection
For the basis o f this study, cases of newly diagnosed central nervous 
system cysticcrcosis presenting to the University o f Southern Califor­
nia teaching hospitals were reviewed. Over a 5-year interval (January 
1982 to January 1987), there were 237 such cases, with a mean age 
of the entire population o f 31.2 years at presentation. In all cases. CT 
scan and/or M R I was performed to aid in the diagnosis and to 
determine the most appropriate therapeutic strategy.
O f the reviewed cases, 20 of 237 patients (8.4%) presented with 
symptomatic large cisternal and/or parenchymal cysts that subse­
quently were surgically drained or removed and were the focus o f the 
present analysis. Inclusion criteria for surgical intervention were: 1) 
rapidly progressive symptoms or neurological deficits from cyst mass 
efTect refractory to an attempted trial o f standard medical therapy 
(fluid restriction, osmotic diuretic, and glucocorticoid administration) 
(15 cases); 2) progression o f symptoms despite the administration of 
the anthelminthic agent praziquantel and glucocorticoids (4 cases): 
and 3) emergent presentation requiring surgical decompression (1 
patient).
The mean age of the patients in this series was 40.2 years, with a 
range of 24 to 64 years. All patients were o f Hispanic origin, and all 
had histories consistent with country of origin or recent travel to an 
endemic area. There was no sex difference (male to female ratio. 1:1). 
Table 1 summarizes the location o f the lesions and their mode of 
presentation.
SURG ICAL M ANAGEM ENT  A N D  RESULTS
Parenchymal cysts
Seven patients in this series presented with large symptomatic 
parenchymal cysts requiring drainage. O f  the 9 large symptomatic 
cysts in the 7 patients (2 patients harbored 2 large cysts), 4 were 
frontal. 3 were frontoparietal (central), and I each were in the 
temporal lobe frontotemporally. These patients underwent a variety 
o f surgical interventions, including stereotactic drainage, craniotomy, 
and burr hole drainage o f a superficial cyst (Table I).
Four patients underwent a primary stereotactic drainage procedure 
with placement of permanent cyst catheter-reservoirs. A Cordis cath­
eter with a Rickham reservoir has proved suitable, and no complica­
tions of catheter obstruction have been encountered with this system. 
The need for subsequent aspiration of the cyst via the indwelling 
catheter was individualized for symptom control among the patients 
in this series, but ranged from 0 to 10 times with an average frequency 
of every 3 weeks. All o f these patients improved clinically and had 
radiographic resolution o f their targeted cysts. The single patient in 
which primary craniotomy was performed for an isolated parenchy­
mal cyst suffered a recurrence; at surgery, adhesions o f the cyst wall 
to the surrounding parenchyma precluded total operative removal. 
He subsequently required a stereotactic procedure with placement of 
a cyst catheter-reservoir for definitive treatment. One patient pre­
sented with large frontal intraparenchymal and suprasellar cisternal 
cysts producing significant mass effect; a frontal craniotomy was 
performed with drainage of the frontal cyst and excision of the 
suprasellar racemose collection, which achieved adequate decompres­
sion and resolution of symptoms. The patient harboring a superficial 
cyst managed by burr hole drainage had no further occurrence of 
cysts.
Cisternal cysts
Twelve patients presented with predominantly cisternal involve­
ment. the most com m on locations being suprasellar. Sylvian, and 
quadrigeminal (Table I). The major symptom associated with these 
large cysts in these locations was headache, whether or not there was 
associated hydrocephalus from major midline shift or intraventricular 
involvement. Focal deficit was present in 25% of these patients and 
was predictable from the location of the lesion (e.g., visual loss with 
a suprasellar cyst and hemiparesis in a patient with a large Sylvian 
lesion). Nine patients underwent primary craniotomy and open re­
section of cysts. In all of these cases, multiple cysts were removed 
from the basilar cisterns at craniotomy; at surgery, the cysts were 
extracted easily with gentle suction and irrigation. All patients re­
ceived preoperative glucocorticoids (dexamcthasone, 4 mg every 6 
hours perioperatively). In the 4 cases of intraoperative cyst rupture, 
there was no incidence of chemical meningitis, as reported by other 
authors (19, 22). O f  the patients who underwent primary craniotomy 
for cyst removal, none required further open surgical intervention. 
One patient, however, did require subsequent shunts for intraventric­
ular involvement and hydrocephalus. Two of the 12 patients were 
treated initially by CT-scan-guided stereotactic puncture and aspira­
tion of the cisternal cysts: both o f these patients required subsequent 
open surgical removal of recurrent lesions because of inadequate 
decompression. This probably was due to the limitation of aspirating 
multiple cysts through a single trajectory. Two patients with moder­
ate-sized quadrigeminal lesions that distorted the tectal region result­
ing in aqueductal stenosis were treated successfully with primary 
ventriculoperitoneal shunts.
Follow-up
There was a total o f 30 operative procedures performed on the 20 
patients. O f  the 30 procedures. 14 were craniotomies, 8 were CSF 
diversions, 1 was a burr hole drainage, and 7 were stereotactic 
procedures (1 aspiration and 6 cyst catheters). Fifteen of the 20 
patients (75%) improved symptomatically over a median follow-up 
period o f 36.4 months. There were no deaths in the series. O f  the 
patients that presented with a neurological deficit. 88% (7 o f 8 
patients) showed either marked improvement or reversal o f their 
deficits. Three patients (15%) experienced surgery-related complica­
tions. In one 54-year-old man, a deep vein thrombosis occurred 1 
week after craniotomy for a suprasellar cyst, which resolved with 
anticoagulant therapy with no sequelae. In another, a cyst catheter- 
reservoir infection by a Gram-negative enteric organism that subse­
quently required open surgical removal for resolution occurred 1 
month postoperatively; the patient suffered a mild left arm paresis 
that was unchanged after 18 months. The third was a complication 
of chronic pncumocephalus after ventriculoperitoneal shunt place­
ment for hydrocephalus. Water-soluble contrast cisternography failed 
to disclose the source of the leak that resolved with conservative 
therapy 3 weeks postoperatively.
ILLUSTRATIVE CASES
Review o f this series permitted analysis o f the medical treatment 
and surgical options for the management o f these lesions.
Case 1: Parenchymal cysts
A 43-year-old Hispanic man presented to the emergency depart­
ment in extremis, exhibiting signs of midbrain compression and 
herniation. A history given by the family indicated several years’ 
history o f tonic clonic seizures treated successfully with phenytoin. A 
CT scan demonstrated a massive left frontal ring-enhancing cyst with 
marked midline shift (Fig. 1. A and B). In addition, low-density 
edema surrounded the lesion. An emergent twist-drill craniostomy
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T a b i .i : 1
Cisternal and Parenchymal Cysts Requiring Surgical Drainage“
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" The numbers in parentheses indicate the number o f cases. Some patients had cysts that required drainage in more than one location. 
’’ * Procedures performed for persistent or recurrent cysts.
was performed with drainage o f approximately 20 ml o f clear fluid. 
The patient's condition improved immediately, and normal mental 
status was achieved w ithin 12 hours o f the procedure. Two days after 
admission, a cyst catheter-reservoir was stereotactically inserted to 
allow repeat aspiration o f the cyst. The cyst was progressively tapped 
to its total resolution over the 7 days after admission (Fig. 1C'). The 
patient subsequently required intermittent cyst aspiration (approxi­
mately every 2 weeks) for recurrent headache for a period of 3 months. 
He was treated for a 14-day period with praziquantel and had reso­
lution of his other smaller parenchymal cysts. He was asymptomatic 
12 months postoperatively.
Cisternal cysts alone and cisternal cysts combined with 
parenchymal cysts
There were 12 patients in the series with predominantly cisternal 
involvement and 4 patients with combined cisternal and either intra- 
parenchymal or intraventricular cysts. This illustrates the occasional 
need for a combination of therapeutic approaches in a single patient.
Case 2
A 49-year-old man who was born in Mexico presented with several 
weeks' history of progressive headache, nausea, and instability of gait. 
A CT scan revealed ventriculomegaly. Ventriculostomy was per­
formed and water-soluble contrast ventriculography revealed obstruc­
tion at the foramen o f Monro, but no intraventricular cyst was 
visualized. A ventriculoperitoneal shunt was placed, and the patient's 
symptoms resolved. He presented again 6 months later with similar 
complaints: a CT scan at that lime revealed multiple large right 
Sylvian cisternal cysts (Fig. 2). Ventricular size had returned to normal 
in the interval since shunt placement. His progressive symptoms 
prompted an open frontotemporal procedure for drainage of the 
Sylvian lesions. Postoperatively. the patient’s symptoms resolved: 
however, he presented again 8 weeks after craniotomy with progres­
sive headache. A CT scan at this admission demonstrated no recur­
rence of the Sylvian lesions but interim development of a large left 
frontal parenchymal cyst. Stereotactic placement of a cyst catheter- 
reservoir was performed, which enabled adequate control of the cyst; 




Cysticcrcosis cellulosa is a cyst 3 to 18 mm in diameter 
found usually in the brain parenchyma (26). Most patients 
with this form of infection are asymptomatic or present with 
seizures. The life span of the larvae is self-limited; the cyst 
usually dies within 7 to 10 years of infestation (24). W ith 
larval death in parenchymal lesions, however, the cyst may 
rapidly enlarge, with imbibition of fluid secondary to a loss 
of osmotic regulation, and produce symptoms by compression 
of surrounding parenchyma (as seen in Case 1). As one might 
expect, and as was the case in 8 patients in our series, this is 
the most frequent time of symptomatic presentation in pa­
tients with large space-occupying cysts.
The use of the anthelminthic agent praziquantel, a hetero­
cyclic pyrazinoisoquinolone (Biltricide. Miles Pharmaceuti­
cals). has been shown in several studies to be effective against 
parenchymal neurocysticercosis (31. 34. 35. 38). Recently, 
another agent, albendazole, has undergone clinical trials in 
Mexico (9. 35. 37). This work suggests that it also is a potent 
antiparasitic. comparable or superior in efficacy to praziquan­
tel in the treatment of this disorder, and is presently the drug 
of choice in Mexico (9. 35). These orally administered agents 
should be considered standard initial therapy for this form of 
disease. One caveat, however, recognized with the use of
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F«i. t. A 43-year-old man with decerebrate postunng and a history o f progressive headache and untreated seizures. An uncnhanccd CT scan 
(.•I) reveals a large left frontal evsi with marked mass elTect. After administration o f intravenous contrast (BK a th in  enhancing cyst wall is 
evident, which suggests Stage 2 disease (dv ing cyst I. Note the additional smaller asymptomatic cysts throughout the parenchyma. The meningeal 
enhancement indicates associated cysticercal arachnoiditis. After stereotactic placement o f a cyst catheter-reservoir, the cyst was progressively 
drained over a pcnod ot I week. A  follow-up C l  scan 2 weeks after admission |C) shows resolution of the large frontal cyst with the indwelling 
catheter. This patient was given pra/iquantcl concurrently and had succcssful resolution o f other intracranial cysts.
pra/iquantcl. is exacerbation o f existing symptoms produced 
by inflammation invoked by the dying cyst, usually manifest 
by transient headache, nausea, and seizures. This may, in 
part, be alleviated with the administration of corticosteroids 
(4, 6, 7). Vazquez, ct al. (43) have demonstrated a reduction 
of plasma levels o f praziquantel by 50'7 with the administra­
tion of dexamethasone: thus, these authors advocate its use 
only if symptoms arc severe (8). In the 4 patients in this series 
treated with praziquantel, symptoms rapidly progressed lo 
require surgical intervention despite its use, but smaller 
asymptomatic parenchymal cysts were successfully eradi­
cated. One liability in its use. therefore, is potential exacer­
bation o f intracranial pressure and symptoms, especially dur­
ing the first week of administration. This series has demon­
strated the existence o f a small subgroup of patients in which 
such a malignant clinical course may necessitate surgical 
intervention.
In the rare case o f parenchymal cysts in which surgical 
intervention is required, there exist several potential surgical 
strategies: I) cyst diversion to the subarachnoid space or 
peritoneal cavity to decrease local mass etTecf. 2) craniotomy 
with drainage of the cystic component and possible removal 
o f the solid mural granuloma: and 3) stereotactic methodol­
ogies for the drainage of cyst contents and biopsv of the wall 
if deemed appropriate.
Primary cyst diversion has fallen from clinical favor for two 
reasons: the potential for seeding o f the infection to other 
cranial or extracranial sites and the production o f chemical 
arachnoiditis or peritonitis from spillage o f toxic cyst contents. 
Craniotomy offers the potential advantage o f open surgical 
excision o f the entire cyst wall and seolex. thereby decreasing 
the rate o f cyst recurrence. Although this seems appealing, 
clinical practice often finds iniraparenchymal cysts adherent 
to surrounding neural and vascular structures, which may 
thwart attempts al total removal of the cysts without neuro­
logical compromise. As noted with intraventricular experi­
ence. prcoperative imaging may provide evidence o f the local 
inflammation surrounding parenchymal and cisternal cysts, 
thus predicting these potential problems in attempting cyst 
removal (2).
In recent years, image-directed stereotaxis has added a new 
perspective to the diagnosis and management o f intracranial 
pathology. Newer stereotaxic apparatus enables the precise 
placement o f indwelling catheter-reservoirs for repeat aspira­
tion of the cystic contents in the management o f intrinsic 
cystic neoplasms and cysticercal lesions ( I ). Realizing that the 
larval form or scolex has an extended life span (7-10 years) 
(24). and that there exists a potential for recurrent accumu­
lation ofthe cyst if it is not totally removed (40). the placement 
of catheter-rescrvoirs for large intrinsic cysts is a viable alter­
native to craniotomy and results in less surgical (especially in 
deep or eloquent locations) and anesthetic (catheters routinely 
placed under local anesthesia) morbidity. In contrast to other 
types o f cystic lesions, the cysticercal walls themselves ofTcr 
no difficulty in puncture, eliminating the need for the use of 
sharp probes that may increase the risk of vascular injury . 
Placement of indwelling eathcter-reservoir systems offers a 
long-term solution to the problem o f cyst rccurrcncc: in 
addition, it provides a margin o f safety by surgical decompres­
sion during the definitive treatment o f the parenchymal dis­
ease bv praziquantel or albendazole. In this series, the inherent 
benefit ofthe stereotactic method in treatment was illustrated 
by the single patient in whom a large cyst was managed 
initially by open craniotomy, defied excision, and subse­
quently recurred. This is in contrast to the patients managed 
stereotacticalK. none of whom required further surgical inter­
vention for their parenchymal disease. Wc have accordingly 
adopted this technique as the primary surgical procedure in 
large symptomatic parenchymal cysts refractory to medical 
therapy.
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Fit.. 2. A 49-year-old man with progressive headache and gait ataxia. The patient had previously undergone vcntriculopentoncal shunting 
for intravcntricular involvement. A CT scan done at admission revealed large right Sylvian cisternal cysts ( I I. A right frontotcmporal craniotomy 
was performed for removal of multiple cysts (U). Postoperatively. the patient’s symptoms resolved, hut he was admitted again after 8 weeks with 
progressive headache. A CT scan at that lime demonstrated resolution o f the Sylvian lesions but showed a large left frontal parenchymal cyst 
that had developed in the interim (C). Stereotactic aspiration and placement o f a cyst catheter-reservoir was undertaken to decrease the mass 
elTcct. A follow-up CT scan a months after craniotomy demonstrated no recurrence o f frontal or cisternal lesions ( I)).
Cisternal cysts
When larvae seed the subarachnoid space there is a more 
ominous prognosis: often, multiple cysts form in grape-like 
clusters that occupy the basilar cisterns, where they may 
produce basilar arachnoiditis with subsequent hydrocephalus, 
cranial neuropathies, and vasculitis (11, 17. 33). These so- 
called cysticercal racemose cysts may reach large proportions 
(several centimeters) and cause symptoms by local mass effect. 
Interestingly, the cysts contain no scolex: whether this repre­
sents a successful immunological response by the host is 
unknown.
The efficacy of praziquantel or albendazole in subarachnoid 
disease is limited in comparison with parenchymal lesions, 
but remission has been reported in some cases (9, 18). The 
12 patients with cisternal involvement presented here all 
demonstrated a progressive tumor-like syndrome (in some 
cases, with neurological deficit) refractory to conservative 
therapy. Although the management of these large cisternal 
lesions is controversial, w'ith several authors recommending 
primary surgical excision of the cysts (25, 30, 42). our expe­
rience would indicate that an initial trial of the drug is 
warranted in a clinically stable patient, recognizing its lim i­
tations in this form of infection. Furthermore, there should 
be no hesitation in proceeding with surgery should symptoms 
persist or progress.
If surgery is considered, the two viable options are open 
craniotomy and stereotactic drainage. In direct contrast to the 
patients harboring parenchymal cysts, all cisternal lesions in 
this series were removed readily by open craniotomy and 
drainage. In the 2 patients in which stereotactic aspiration 
was attempted, inadequate decompression was achieved be­
cause of the multiple (racemose) cysts characteristic of these 
locations. In the absencc of radiographic evidence of inflam­
mation (by contrast enhancement on CT scan), these basilar 
racemose cysts were resected with case, using gentle irrigation 
and traction: in all but 4 cases, they were removed intact. 
Other reports, however, have acknowledged some difficulty 
using this approach with ring-enhancing cisternal lesions, but 
marsupialization may be possible (18. 30).
The surgical results o f this small series of parenchymal and 
cisternal lesions compares favorably with those reported by 
Stepien (39), in which 63 Stage 1 patients (those with large 
cysts presenting as space-occupying tumors) were treated by 
primary craniotomy and attempted cyst removal (before the 
advent of praziquantel). A total of 74.5% of the patients 
improved or recovered, but with an associated 23.6% post­
operative mortality.
In conclusion, our experience in the management of 20 
cases of large symptomatic cisternal and parenchymal cysti­
cercal cysts indicates that such large cysts may be amenable 
to surgery if they are rapidly progressive or refractory to 
medical therapy. Symptomatic intraparenchymal cysts are 
best managed by stereotactic methods with placement of cyst 
catheter-reservoirs to allow serial aspiration during a treat­
ment course with praziquantel or albendazole. Large basilar 
cisternal cysts are best managed by open craniotomy and 
excision in the absence of radiographically discernible basilar 
arachnoiditis that would preclude their removal.
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CO M M ENT
Praziquantel and albendazole have had a major impact on 
the treatment of parenchymal neural cysticercosis. ln this 
article, the authors have given us a good update on the role 
of surgical management of this disease in the era of effective 
medical management. The authors make a logical case for 
dividing intracranial cysticercosis into parenchymal and cis­
ternal forms, for which primary surgical treatment is difficult. 
Their experience, although relatively limited, clearly supports 
their conclusion that parenchymal cysts requiring surgical 
treatment despite adequate medical therapy seem to be well 
treated by aspiration. The advice to place a catheter-reservoir 
system for repeated aspiration is well taken. The efficacy of 
open excision for cisternal disease is also reasonably well 
documented. Based on existing knowledge, the authors’ ad­
vice on management seems appropriate. It will be interesting 
to see whether this experience is replicated in centers where 
the disease is more prevalent.
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